Expression of Transcription Factor E2F1 and Telomerase in Glioblastomas: Mechanistic Linkage and Prognostic Significance

• Published in: JNCI : Journal of the National Cancer Institute 2005-11, Vol.97 (21), p.1589-1600
• Main Authors: Alonso, Marta M., Fueyo, Juan, Shay, Jerry W., Aldape, Kenneth D., Jiang, Hong, Lee, Ok-Hee, Johnson, David G., Xu, Jing, Kondo, Yasuko, Kanzawa, Takao, Kyo, Satoru, Bekele, B. Nebiyou, Zhou, Xian, Nigro, Janice, McDonald, J. Matthew, Yung, W. K. Alfred, Gomez-Manzano, Candelaria
• Format: Article
• Language: English
• Subjects: Adenovirus; Animals; Binding sites; Biological and medical sciences; Brain; Brain Neoplasms - enzymology; Brain Neoplasms - metabolism; Cancer; Cell Line, Tumor; Chromatin Immunoprecipitation; DNA-Binding Proteins - metabolism; E2F1 Transcription Factor - genetics; E2F1 Transcription Factor - metabolism; Gene expression; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genetic Linkage; Glioblastoma - enzymology; Glioblastoma - metabolism; Humans; Immunoblotting; Medical sciences; Mice; Mice, Transgenic; Neurology; Predictive Value of Tests; Prognosis; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger - metabolism; Sarcoma - enzymology; Sarcoma - metabolism; Telomerase - metabolism; Tumors; Tumors of the nervous system. Phacomatoses
• ISSN: 0027-8874; 1460-2105
• DOI: 10.1093/jnci/dji340

Background: Several tumor suppressor pathways have been identified as modulators of telomerase function. We examined the functional role of the retinoblastoma-E2F1 pathway in regulating telomerase activity in malignant gliomas. Methods: Adenovirus vectors were used to transfer cDNAs into human glioblastoma and sarcoma cells. Telomerase activity was assessed with a telomere repeat amplification protocol. Promoter activity in cancer cells was assessed with promoter–luciferase reporter constructs. Promoter binding was assessed with the chromatin immunoprecipitation (ChIP) assay. We isolated astrocytes from E2F1 transgenic mice and normal mice for in vivo studies. We evaluated the expression of E2F1 and hTERT (the catalytic subunit of human telomerase) mRNAs by reverse transcriptase–polymerase chain reaction and proteins in human glioblastoma samples by immunoblot analysis. Associations between survival among 61 glioblastoma multiforme patients and expression of E2F1 and hTERT mRNA and protein were examined with Kaplan–Meier analysis, the log-rank test, and Cox proportional hazards regression models. All statistical tests were two-sided. Results: Ectopic E2F1 expression increased hTERT promoter activity in cancer cells. We detected an interaction between E2F1 protein and the hTERT promoter. Transgenic E2F1 astrocytes contained functional telomerase protein. E2F1 mRNA expression and hTERT mRNA expression were statistically significantly correlated in human glioblastoma specimens (R = .8; P